Search - tctmd.com

Displaying 121 - 140 of 420

Sort: Relevancy | Date

Icosapent Ethyl’s Benefits Consistent in Patients With Prior PCI: REDUCE-IT

News Conference News TCT 2020

Icosapent Ethyl’s Benefits Consistent in Patients With Prior PCI: REDUCE-IT

October 21, 2020

Under ISCHEMIA’s Long Shadow, Cardiologists Ponder Shifting Guidelines, Care

News Conference News TCT 2020

Under ISCHEMIA’s Long Shadow, Cardiologists Ponder Shifting Guidelines, Care

Michael O'Riordan

October 19, 2020

MITHRAS: No Upside to Closing iASDs Caused by Transcatheter MV Interventions

News Conference News TCT 2020

MITHRAS: No Upside to Closing iASDs Caused by Transcatheter MV Interventions

October 15, 2020

In My Opinion: How Should Revascularization Guidelines Change After ISCHEMIA?

Presentation TCT 2020

In My Opinion: How Should Revascularization Guidelines Change After ISCHEMIA?

Presenter: Davide Capodanno

October 15, 2020

Bivalirudin vs Heparin Patient-Level Meta-analysis Stirs an Old Debate

News Conference News TCT 2020

Bivalirudin vs Heparin Patient-Level Meta-analysis Stirs an Old Debate

October 14, 2020

STEMI Door-to-Balloon Times Haven’t Suffered During COVID-19: NACMI

News Conference News TCT 2020

STEMI Door-to-Balloon Times Haven’t Suffered During COVID-19: NACMI

October 14, 2020

Off Script: PCI of the Future? Let’s Break Down the Border Between Physiology and Anatomy

News Opinion Off Script TCT 2019

Off Script: PCI of the Future? Let’s Break Down the Border Between Physiology and Anatomy

October 14, 2019

In-Hospital Mortality Hasn’t Budged Despite Changes in MCS for Cardiogenic Shock

News Conference News TCT 2019

In-Hospital Mortality Hasn’t Budged Despite Changes in MCS for Cardiogenic Shock

October 04, 2019

TICAKOREA: Ticagrelor Ups Bleeding Over Clopidogrel in Korean ACS Patients

News Conference News TCT 2019

TICAKOREA: Ticagrelor Ups Bleeding Over Clopidogrel in Korean ACS Patients

October 03, 2019

FORZA: For Intermediate Lesions, OCT-Guided PCI Costs More, Yields Better Outcomes vs FFR

News Conference News TCT 2019

FORZA: For Intermediate Lesions, OCT-Guided PCI Costs More, Yields Better Outcomes vs FFR

October 01, 2019

News Conference News TCT 2019

GLOBAL LEADERS Post Hoc: Okay to Drop Aspirin After 1 Month in ACS Patients?

September 30, 2019

Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA

News Conference News TCT 2019

Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA

Michael O'Riordan

September 28, 2019

DAPT After PCI With DCB: Current Guidelines and Special Considerations

Presentation TCT 2019

DAPT After PCI With DCB: Current Guidelines and Special Considerations

Presenter: Marco Valgimigli

September 28, 2019

What the Guidelines Do and Don't Tell Us: The Unmet Clinical Needs

Presentation TCT 2019

What the Guidelines Do and Don't Tell Us: The Unmet Clinical Needs

Presenter: Ralph von Bardeleben

September 28, 2019

Case Presentation: A Real-World Case of Functional TR Not Considered in the Guidelines

Presentation TCT 2019

Case Presentation: A Real-World Case of Functional TR Not Considered in the Guidelines

Presenter: Antonio Mangieri

September 28, 2019

Surgical Volume Matters When It Comes to Repair of Primary MR

News Conference News TCT 2019

Surgical Volume Matters When It Comes to Repair of Primary MR

September 28, 2019

Perioperative Antiplatelet Management: What Do the Guidelines Say?

Presentation TCT 2019

Perioperative Antiplatelet Management: What Do the Guidelines Say?

Presenter: Subhash Banerjee

September 27, 2019

TCT Live Blog Day 2

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Two: Transcatheter Valves, New and Old

September 27, 2019

Revascularization in Stable CAD: What Do the New 2019 ESC Guidelines Recommend?

Presentation TCT 2019

Revascularization in Stable CAD: What Do the New 2019 ESC Guidelines Recommend?

Presenter: Jean Fajadet

September 27, 2019

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

News Conference News TCT 2019

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

September 26, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.